Biofil Chemicals & Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
BSE Code : 524396 |
NSE Symbol : BIOFILCHEM |
P/E(TTM) : 199.74 |
ISIN Demat : INE829A01014 |
Div & Yield% : - |
EPS(TTM) : 0.39 |
Book Value(₹) : 11.19 |
Market Cap(₹Cr) : 126.74 |
Face Value(₹) : 10.00 |
Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|---|
Gross Sales | 8.44 | 15.20 | 5.03 | 17.37 | 2.43 | 13.62 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 8.44 | 15.20 | 5.03 | 17.37 | 2.43 | 13.62 |
Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income | 0.03 | 0.41 | 0.03 | 0.03 | 0.02 | 0.03 |
Total Income | 8.47 | 15.61 | 5.06 | 17.40 | 2.46 | 13.65 |
Total Expenditure | 8.14 | 15.24 | 4.84 | 17.13 | 2.02 | 13.21 |
PBIDT | 0.34 | 0.37 | 0.22 | 0.27 | 0.44 | 0.44 |
Interest | 0.01 | 0.02 | 0.00 | 0.01 | 0.01 | 0.01 |
PBDT | 0.33 | 0.35 | 0.22 | 0.26 | 0.43 | 0.43 |
Depreciation | 0.10 | 0.08 | 0.11 | 0.11 | 0.11 | 0.11 |
Tax | 0.06 | 0.11 | 0.02 | 0.03 | 0.08 | 0.11 |
Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 0.00 | -0.08 | 0.00 | 0.00 | 0.00 | 0.00 |
Reported Profit After Tax | 0.17 | 0.25 | 0.09 | 0.12 | 0.24 | 0.21 |
Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adjusted Profit After Extra-ordinary item | 0.17 | 0.25 | 0.09 | 0.12 | 0.24 | 0.21 |
EPS (Unit Curr.) | 0.10 | 0.15 | 0.06 | 0.08 | 0.15 | 0.07 |
EPS (Adj) (Unit Curr.) | 0.10 | 0.15 | 0.06 | 0.08 | 0.15 | 0.07 |
Calculated EPS (Unit Curr.) | 0.10 | 0.15 | 0.06 | 0.08 | 0.15 | 0.13 |
Calculated EPS (Adj) (Unit Curr.) | 0.10 | 0.15 | 0.06 | 0.08 | 0.15 | 0.13 |
Calculated EPS (Ann.) (Unit Curr.) | 0.42 | 0.61 | 0.23 | 0.30 | 0.60 | 0.51 |
Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.42 | 0.61 | 0.23 | 0.30 | 0.60 | 0.51 |
Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity | 16.27 | 16.27 | 16.27 | 16.27 | 16.27 | 16.27 |
Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PBIDTM(%) | 4.03 | 2.43 | 4.37 | 1.55 | 18.11 | 3.23 |
PBDTM(%) | 3.91 | 2.30 | 4.37 | 1.50 | 17.70 | 3.16 |
PATM(%) | 2.01 | 1.64 | 1.79 | 0.69 | 9.88 | 1.54 |